The U.S. Food and Drug Administration (FDA) has cleared Tenax Therapeutics to begin clinical testing of its new oral…
Articles by Marisa Wexler, MS
Targeting a protein called p110a, a part of the PI3K family of enzymes, may be useful for preventing or even…
A lab version of an investigational treatment for bone disorders and pulmonary arterial hypertension (PAH), KER-012Â prevented bone loss…
Blocking the activity of a small RNA molecule called microRNA-30a eased alterations in heart structure and blood vessel architecture in…
Many people with chronic thromboembolic pulmonary hypertension or CTEPH have a particular anatomical variation called May-Thurner anatomy, which may…
COVID-19 tends not to cause serious disease or death in children with pulmonary hypertension (PH), but its long-term consequences…
Health-related quality of life does not change substantially over time among people with pulmonary arterial hypertension (PAH) — though…
A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop…
Regularly consuming low-alcohol red wine reduced signs of pulmonary arterial hypertension (PAH) in a rat model of the disease,…
As part of the company’s Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, Bayer is giving a total of $1 million…
Apabetalone (RVX-208), Resverlogix‘s experimental treatment for pulmonary arterial hypertension (PAH), was well-tolerated in a small clinical trial, the…
For premature babies who are at high risk of pulmonary hypertension (PH) and other cardiovascular complications, consuming human breast milk…